Heartwood Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$470K Buy
392
+10
+3% +$10.2K 0.04% 144
2026
Q1
$351K Buy
+382
New +$387K 0.03% 158
2025
Q4
Sell
-172
Closed -$131K 427
2025
Q3
$131K Buy
+172
New +$128K 0.01% 234
2024
Q4
Sell
-244
Closed -$216K 177
2024
Q3
$216K Sell
244
-43
-15% -$38.7K 0.02% 166
2024
Q2
$260K Hold
287
0.03% 144
2024
Q1
$223K Buy
+287
New +$204K 0.03% 145
2023
Q3
Sell
-887
Closed -$416K 138
2023
Q2
$416K Buy
+887
New +$372K 0.06% 90

Other funds holding LLY

Heartwood Wealth Advisors's LLY Position: Q2 2026 in Review

Heartwood Wealth Advisors increased its Eli Lilly (LLY) stake by 2.6% in Q2 2026, buying an estimated $10.2K and bringing the position to 392 shares worth $470K. The position accounts for 0.04% of the portfolio, ranked #144.

Heartwood Wealth Advisors first reported a position in LLY in Q2 2023 and has held it in 7 quarters since. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Heartwood Wealth Advisors held 392 shares of Eli Lilly worth $470K as of Q2 2026.
  • Heartwood Wealth Advisors bought 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
  • Eli Lilly made up 0.04% of Heartwood Wealth Advisors's portfolio in Q2 2026, its #144 holding.
  • Heartwood Wealth Advisors first reported a position in Eli Lilly in Q2 2023 and has held it in 7 quarters since.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Heartwood Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.